Plakous Therapeutics is a Winston-Salem, North Carolina–based biotherapeutic company developing placenta-derived regenerative therapies. Its lead product is Protego-PD™, described as the company’s first regenerative medicine product. The company intends to use the recently raised funds for ongoing development and marketing of Protego-PD™. Plakous is led by CEO Robert Boyce. The company positions its therapies as improving patient outcomes while reducing health care costs. FinSMEs reported the funding on 08/07/2022.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2022